For help on how to get the results you want, see our search tips.
30 results
-
List item
Referral: Actira
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Arcoxia
etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, Last updated: 21/11/2008 -
List item
Referral: Avelox
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Bifril, Teoula, Zofepril, Zopranol
zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, Last updated: 29/11/2000 -
List item
Referral: Bupropion hydrochloride
bupropion, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 25/07/2002, EC decision date: 25/10/2002, Last updated: 06/12/2002 -
List item
Referral: Cardiostad
lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, Last updated: 01/03/2003 -
List item
Referral: Cerivastatin
cerivastatin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/03/2002, EC decision date: 22/08/2002, Last updated: 20/12/2002 -
List item
Referral: Coversyl
Perindopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2005, EC decision date: 07/11/2005, Last updated: 23/12/2005 -
List item
Referral: Ethinylestradiol-Drospirenone 24+4
ethinylestradiol / drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013 -
List item
Referral: Extraneal
icodextrin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 20/01/2010, Last updated: 27/10/2009 -
List item
Referral: Gadograf, Gadovist
gadobutrol, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 13/04/2007, Last updated: 09/11/2007 -
List item
Referral: Genotropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, EC decision date: 26/06/2003, Last updated: 29/08/2003 -
List item
Referral: Genotropin
somatropin, associated names: Genotonorm, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 02/09/2010, Last updated: 26/04/2011 -
List item
Referral: Goserelin Cell Pharm
goserelin, associated names: Novosis Goserelin, Goserelin Cell Pharm, Novimp and associated names, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, Last updated: 06/02/2012 -
List item
Referral: Laurina
Desogestrel/ethinlestradiol, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/09/2003, EC decision date: 05/02/2004, Last updated: 01/03/2004 -
List item
Referral: Lisinopril Biochemie
Lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, Last updated: 01/09/2003 -
List item
Referral: MultiHance
gadobenic acid, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2000, EC decision date: 15/09/2000, Last updated: 15/12/2000 -
List item
Referral: Norditropin
Somatropin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2003, Last updated: 29/08/2003 -
List item
Referral: Novimp
goserelin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, Last updated: 06/02/2012 -
List item
Referral: Novosis Goserelin
goserelin, associated names: Goserelin Novosis, Gosacin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, Last updated: 06/02/2012 -
List item
Referral: Octegra
moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008 -
List item
Referral: Preflucel
influenza vaccine, purified antigen, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 10/12/2012, Last updated: 20/07/2012 -
List item
Referral: Prozac
Fluoxetine, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 01/06/2006, EC decision date: 21/08/2006, Last updated: 05/09/2006 -
List item
Referral: Salmeterol and Fluticasone Propionate
Salmeterol and fluticasone, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/01/2003, EC decision date: 21/05/2003, Last updated: 31/07/2003 -
List item
Referral: Sertindole
Sertindole, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 20/10/2000, EC decision date: 20/01/2000, Last updated: 19/09/2002